}
  • Home   ›
  •   Indian Tenders   › Tender Notice : 46013408

    • Bids Are Invited For First Line Anti Tb Drugs For Ntep - Ethambutol 800 Mg Tablet (Q1) (V2) (Q2) , Lignocaine Injection (Q2) , Ondansetron Injection (Q2) Pyridoxine 100 Mg Tablets (Q1) Total Quantity : 2840, Meerut-Uttar Pradesh

    Indian Army has published Bids Are Invited For First Line Anti Tb Drugs For Ntep - Ethambutol 800 Mg Tablet (Q1) (V2) (Q2) , Lignocaine Injection (Q2) , Ondansetron Injection (Q2) Pyridoxine 100 Mg Tablets (Q1) Total Quantity : 2840. Submission Date for this Tender is 14-11-2024. Medicine Tenders in Meerut Uttar Pradesh. Bidders can get complete Tender details and download the document.




    Tender Notice

    46013408
    Bids Are Invited For First Line Anti Tb Drugs For Ntep - Ethambutol 800 Mg Tablet (Q1) (V2) (Q2) , Lignocaine Injection (Q2) , Ondansetron Injection (Q2) Pyridoxine 100 Mg Tablets (Q1) Total Quantity : 2840
    Open Tender
    NCB
    Uttar Pradesh
    Meerut
    14-11-2024

    Tender Details

    Bids Are Invited For First Line Anti Tb Drugs For Ntep - Ethambutol 800 Mg Tablet (Q1) (V2) (Q2) , Lignocaine Injection (Q2) , Ondansetron Injection (Q2) Pyridoxine 100 Mg Tablets (Q1) Total Quantity : 2840

    Key Value

    Document Fees
    Refer document
    EMD
    Refer document
    Tender Value
    Refer document
    Disclaimer :
    We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
    Tell us about your Product / Services,
    We will Find Tenders for you
    Cnet Technologies

    We are a group of professionals specializing in custom software development, web development, mobile app development, IOT base solutions, web design, graphics & Enterprise solutions provid.

    About Us

    Services

    Browse Tenders

    For Sales Inquiry

    Connect With Us

    Copyright © 2025 · All Rights Reserved. Terms of Usage | Privacy Policy

    For Tender Information Services Visit : TenderDetail